Glutathione Production on a BiomeFx Panel Glutathione is a powerful antioxidant produced in the body, playing a critical role in protecting cells from oxidative stress and maintaining overall cellular health. On a BiomeFx panel, the marker for glutathione production indicates the capacity of the gut microbiota to contribute to the synthesis of this vital molecule. Adequate glutathione levels are essential for detoxification processes, immune function, and the neutralization of free radicals. Low levels of glutathione production can be associated with increased susceptibility to chronic diseases, inflammation, and compromised immune response. Factors influencing glutathione production include diet, lifestyle, gut health, and genetic predispositions. Monitoring and supporting glutathione production through nutritional interventions, such as increasing intake of sulfur-rich foods (e.g., garlic, onions, cruciferous vegetables), antioxidants, and specific supplements, can enhance the body’s antioxidant defenses and promote overall well-being.

Part of Blood Health

Glutathione (GSH) is a tripeptide (λ-glutamyl-cysteinylglycine) synthesized by most cells, serving as a critical marker of cellular health and resilience against toxic stress. In erythrocytes, GSH levels are a sensitive indicator of the body's intracellular GSH status and overall cellular well-being. It is the most abundant non-protein thiol in mammalian cells, playing key roles in various biological processes, such as detoxifying harmful compounds (xenobiotics), neutralizing reactive oxygen species, regulating cellular redox balance, and maintaining the oxidative state of vital protein sulfhydryl groups. Additionally, GSH supports immune function. Intracellular GSH concentrations are significantly higher than plasma levels, with plasma GSH largely derived from the liver. The active form, reduced GSH (rGSH), is maintained at a ratio of approximately 9:1 with its oxidized counterpart (GSSH) in healthy cells. However, once a blood sample is collected, erythrocyte rGSH is highly prone to oxidation, rapidly diminishing the rGSH ratio. Due to the impracticality of preventing ex vivo oxidation and the challenges of directly measuring rGSH in clinical settings, it is more feasible to assess total erythrocyte GSH as an indicator of overall GSH status. Research suggests that an unfavorable rGSHratio is closely associated with abnormally low total cellular GSH levels.

Gluten (F79) IgG is a specific immunoglobulin G antibody marker used in the immunological assessment of gluten sensitivity and related disorders. This antibody targets a fraction of gluten proteins, primarily found in wheat and related grains, and its presence in the bloodstream can be indicative of an immune response to gluten ingestion. Unlike IgA antibodies, which are more commonly associated with celiac disease, IgG antibodies are not typically specific to celiac but rather suggest a broader gluten sensitivity or intolerance. High levels of Gluten (F79) IgG antibodies may be present in individuals with non-celiac gluten sensitivity (NCGS), a condition characterized by gastrointestinal and extraintestinal symptoms related to gluten ingestion, without the autoimmune or allergic mechanisms of celiac disease or wheat allergy. The testing for Gluten (F79) IgG is crucial for distinguishing between these conditions, as the management and dietary modifications differ significantly. Moreover, this marker is valuable in monitoring the immune response in individuals who have already adopted a gluten-free diet, as it helps assess the effectiveness of dietary compliance and changes. However, the interpretation of Gluten (F79) IgG levels should be approached with caution, as elevated levels can also occur in other conditions and even in healthy individuals without gluten-related disorders, thus necessitating a comprehensive clinical assessment alongside serological testing.